WTC2025 APP and Final Program are now available!

Download the Digital Program PDF

Congress App is now available

To make the most of your Congress experience, please download the official mobile app to access the full scientific program, connect with fellow delegates, build a personalized schedule, and more.

Mobile App Download Instructions:

Scan the QR codes below to download the app. Alternatively, you can search for “The Event App by EventsAIR” in your device’s app store. Once downloaded, enter the following event code: wtc2025 Log-in using the email address and PIN provided in your final confirmation email. Please do not share your PIN – it is unique and linked to your personal registration record.

Visit the TTS2026 Booth @ WTC 2025!

Our booth is at the main entrance of the exhibit hall — come say hello and connect with our team!

  • 🎁 Enter our raffle for exciting prizes
  • 🎯 Play our spin-the-wheel game for bonus giveaways
  • 👋 Discover what’s coming for TTS 2026 in Sydney and more!
  • Don’t miss it — see you there!


TTS2026 Call for Ideas & Session Proposals is Now Open!

Be part of shaping the future of transplantation at the 31st International Congress of The Transplantation Society (TTS 2026) in Sydney, Australia, September 20–23, 2026! 

Under the theme Innovation through Collaboration, we’re inviting the global transplantation community to submit ideas that will make this a truly exceptional event. Whether it’s a full session proposal, a topic suggestion (with or without speakers), an innovative session format, a networking concept, or a fresh idea to enhance the attendee experience, your input matters. The Scientific Program Committee will review all submissions to complement the core program and ensure diverse, impactful, and forward-thinking content. 

Deadline: August 28, 2025.


Exploring the Future of Transplantation: A Three-Part Webinar Series - View Recordings!

In Collaboration with The Lancet Journal, the American Society of Transplantation, and The European Society of Organ Transplantation

Exploring the Future of Transplantation: A Three-Part Webinar Series

Solid organ transplantation continues to transform the lives of patients with end-stage organ failure. Yet major challenges persist, including the global shortage of donor organs, the side effects of long-term immunosuppression, and persistent inequities in access to care. This three-part webinar series highlights key findings from The Lancet's recent clinical Series on organ transplantation.


Read the full description of the series

The Lancet launched its Clinical Series on Solid Organ Transplantation in response to rapid scientific advances that are transforming the field. Transplantation has long faced three major challenges:

  1. a shortage of transplantable organs;
  2. the toxicities of imprecise immunosuppression that cause patients to suffer complications including infections, cancer, and rejection of the allograft; and
  3. inequities in access to transplantation and disparities in outcomes after transplantation.

Transplant scientists have a strong tradition of driving progress through interdisciplinary collaboration drawing on fields as varied as immunology, engineering, and ethics. Today, progress is accelerating.

The first paper in the Series reports on solutions to the problem of a lack of organs. These innovations include better preservation and new capabilities of repairing human deceased donor organs through next-generation perfusion pumps, as well as the creation of bioengineered pig organs for transplant.

The second Series paper describes novel tools for precision immunosuppression such as cell-free DNA that enable clinicians to customize medical regimens to the needs of individual transplant recipients. When transplanted organs suffer injury, novel techniques from molecular pathology enable clinicians to better diagnose rejection with deep phenotyping of allograft biopsies.

The final manuscript turns to health equity and proposes policy strategies to ensure that the benefits of transplantation extend to all patients with end-stage organ disease who need a transplant, both nationally and globally.

This illuminating Series will be followed by a Lancet Commission on transplantation, which brings together leaders from multiple countries to chart a path forward for the field over the next decade or more.


For more information on the publications featured in The Lancet, visit: https://www.thelancet.com/series-do/organ-transplantation

Recording & Podcast
Are Now Available!
Recording & Podcast
Are Now Available!
Recording & Podcast
Are Now Available!

Transplantation Journal Highlights

Transplantation Journal - Social Media Content

Pregnancy Outcomes Using Assisted Reproductive Technology in Kidney Transplant Recipients
Infertility is common among those with kidney transplants, and pregnancy is associated with a high risk of adverse maternal and fetal outcomes. Little is known about the outcomes of pregnancy with assisted reproductive technology (ART) in women with kidney transplants.
Clinical Manifestation, Mechanisms, and Potential Targets of Intervention for Chronic Rejection in Vascularized Composite Allotransplantation
As the field of vascularized composite allograft (VCA) has matured, chronic rejection (CR) has emerged as the major cause of late graft loss, albeit occurring at a lower frequency than in many solid organ transplants. VCAs differ from conventional solid organ transplants in that they have multiple tissue targets and CR types. Exposure to environmental, physical, or thermal trauma has been shown to start or worsen both acute and CR in VCA recipients.

Transplantation Direct - Social Media Content

Allogeneic Liver Transplantation in Nonhuman Primates: Surgical Technique With Stable Postoperative Outcomes
Nonhuman primate models are essential in preclinical transplantation studies. Although many advances in medical and surgical therapies have been achieved in liver transplantation research using rodent models, nonhuman primate models have not been widely used because of their technical complexity. As scientific inquiries into tolerance-free and ischemia-free models of transplantation continue to progress, it is vital to establish a standard nonhuman primate model. We attempted to establish a feasible and stable nonhuman primate model for orthotopic liver transplantation using baboons.
Thrombotic Microangiopathy After Kidney Pancreas Transplant Managed With Eculizumab and a Calcineurin Inhibitor-free Basiliximab/Belatacept Maintenance Regimen: Between a Rock and a Hard Place
Thrombotic microangiopathy (TMA) is a rare but significant complication after kidney transplant, resulting in graft loss in more than one-third of cases with systemic manifestations. TMA is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ injury resulting from endothelial damage and microthrombi formation in small vessels. In the context of kidney transplantation, TMA can manifest as either a systemic condition with microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure or as a localized form leading to progressive renal dysfunction, proteinuria, or hypertension.

ITS 2025 - Early-bird Registration is Open

Join us for the 2025 International Transplantation Science meeting (ITS 2025) and connect with the leading global transplantation community!

On behalf of AST, ESOT and TTS, we wish to extend to you a warm welcome to the 2025 International Transplant Science meeting in San Diego, California USA.

Early-bird Registration Deadline: August 31


MESOT 2025 - Pre-Congress Workshop Announcement

Join us for the 19th Congress of the Middle East Society for Organ Transplantation (MESOT 2025)

On behalf of MESOT, we warmly welcome you to Ankara, Turkey, November 5–7, 2025, for this milestone meeting, held alongside the 50th Anniversary of Organ Transplantation in Turkey.

ISUTx 2025 - Final Program Now Available

The International Society of Uterus Transplantation is excited to share with you the final program for ISUTx 2025.

Early-bird registration remains open until August 15 -- Secure your spot today and save!


2025 Advancing Diversity, Equity & Inclusion in Transplantation Conference

Early-bird Registration Deadline: August 10, 2025

It is our great pleasure to invite you to attend the 2025 Advancing Diversity, Equity & Inclusion in Transplantation: A Global Perspective Conference, taking place October 25 - 26, 2025 in Toronto, Ontario. This second edition will be co-located with the 6th Congress of International Advanced HBP Surgery (ISLS 2025).

TTS members are eligible for a reduced registration fee of $250.00.


In the News


Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada